PDL BIOPHARMA, INC. (33) | Business Finance (14)

Browse by Subcategory

Recent Contracts

Capital Provision Agreement dated as of December 11, 2020 between the Company and Epps Investments LLC (Filed With SEC on March 29, 2021)
Share Purchase Agreement between Bartleby Limited and the Company, dated as of July 30, 2020 (Filed With SEC on August 10, 2020)
Form of Restricted Stock Agreement (Amended 11/15/19) (Filed With SEC on March 11, 2020)
Indenture, dated September 17, 2019, between PDL, BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee (Filed With SEC on September 17, 2019)
Form of Exchange Agreement (Filed With SEC on September 13, 2019)
Securities Purchase Agreement (Filed With SEC on April 11, 2019)
Form of Restricted Stock Agreement Amendment Acknowledgment (Filed With SEC on March 11, 2020)
Form of Stock Option Agreement (Amended 11/15/19) (Filed With SEC on March 11, 2020)
Form of Stock Option Agreement Amendment Acknowledgment (Filed With SEC on March 11, 2020)
Form of Stock Option Grant Notice Supplement (Filed With SEC on March 11, 2020)
Form of Nonstatutory Inducement Stock Option Agreement (Amended 11/15/19) (Filed With SEC on March 11, 2020)
Form of Nonstatutory Inducement Stock Option Grant Notice Supplement (Filed With SEC on March 11, 2020)
Form of Inducement Restricted Stock Agreement (Amended 11/15/19) (Filed With SEC on March 11, 2020)
Supplemental Indenture, dated September 17, 2019 by and between PDL BioPharma, Inc., as Issuer and The Bank of New York Mellon Trust Company, N.A., as Trustee (Filed With SEC on September 17, 2019)